Andrew J. Racher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew J. Racher has a total of 164 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Mark Smales
School of Natural Sciences, University of Kent, CT2 7NJ, Canterbury, UK
13 shared publications John R. Birch
8 shared publicationsRobert J. Young
Cell Engineering Group, Lonza Biologics, Chesterford Research Park, Building 200, Little Chesterford, CB10 1XL, UK
8 shared publications- David C. James
Department of Chemical and Biological Engineering, Mappin St., The University of Sheffield, Sheffield, S1 3JD
5 shared publications Colin Jaques
4 shared publicationsD. Looby
PHLS CAMR, Biologics Division, Porton Down, Salisbury, Wiltshire, UK
4 shared publications
Latest Publications
- Open Access
- 1 December 2021
- Published by Elsevier in Metabolic Engineering Communications
- Vol. 13, e00179
A proline metabolism selection system and its application to the engineering of lipid biosynthesis in Chinese hamster ovary cells
- 1 December 2021
- Published by Elsevier in Metabolic Engineering Communications
- Vol. 13, e00179
Open AccessA proline metabolism selection system and its application to the engineering of lipid biosynthesis in Chinese hamster ovary cells
- 1 July 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 152, 193-201
Tracking the physical stability of fluorescent-labeled mAbs under physiologic in vitro conditions in human serum and PBS
- 1 July 2020
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 152, 193-201
Tracking the physical stability of fluorescent-labeled mAbs under physiologic in vitro conditions in human serum and PBS
- Open Access
- 1 April 2020
- Published by Elsevier in Data in Brief
- Vol. 29, 105217
Data for engineering lipid metabolism of Chinese hamster ovary (CHO) cells for enhanced recombinant protein production
- 1 April 2020
- Published by Elsevier in Data in Brief
- Vol. 29, 105217
Open AccessData for engineering lipid metabolism of Chinese hamster ovary (CHO) cells for enhanced recombinant protein production
- Open Access
- 1 January 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 57, 203-216
Engineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production
- 1 January 2020
- Published by Elsevier in Metabolic Engineering
- Vol. 57, 203-216
Open AccessEngineering of Chinese hamster ovary cell lipid metabolism results in an expanded ER and enhanced recombinant biotherapeutic protein production
- Open Access
Intact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines
The use of cell lines in research can be affected by cell line misidentification. Short tandem repeat (STR) analysis is an effective method, and the gold standard, for the identification of the genetic origin of a cell line, but methods that allow the discrimination between cell lines of the same genetic origin are lacking. Here, we use intact cell MALDI-ToF mass spectrometry analysis, routinely used for the identification of bacteria in clinical diagnostic procedures, for the authentication of a set of cell lines consisting of three parental neuroblastoma cell lines (IMR-5, IMR-32 and UKF-NB-3) and eleven drug-adapted sublines. Principal component analysis (PCA) of intact-cell MALDI-ToF mass spectrometry data revealed clear differences between most, but not all, of the investigated cell lines. Mass spectrometry whole-cell fingerprints enabled the separation of IMR-32 and its clonal subline IMR-5. Sublines that had been adapted to closely related drugs, for example, the cisplatin- and oxaliplatin-resistant UKF-NB-3 sublines and the vincristine- and vinblastine-adapted IMR-5 sublines, also displayed clearly distinctive patterns. In conclusion, intact whole-cell MALDI-ToF mass spectrometry has the potential to be further developed into an authentication method for mammalian cells of a common genetic origin.
Open AccessIntact-Cell MALDI-ToF Mass Spectrometry for the Authentication of Drug-Adapted Cancer Cell Lines
The use of cell lines in research can be affected by cell line misidentification. Short tandem repeat (STR) analysis is an effective method, and the gold standard, for the identification of the genetic origin of a cell line, but methods that allow the discrimination between cell lines of the same genetic origin are lacking. Here, we use intact cell MALDI-ToF mass spectrometry analysis, routinely used for the identification of bacteria in clinical diagnostic procedures, for the authentication of a set of cell lines consisting of three parental neuroblastoma cell lines (IMR-5, IMR-32 and UKF-NB-3) and eleven drug-adapted sublines. Principal component analysis (PCA) of intact-cell MALDI-ToF mass spectrometry data revealed clear differences between most, but not all, of the investigated cell lines. Mass spectrometry whole-cell fingerprints enabled the separation of IMR-32 and its clonal subline IMR-5. Sublines that had been adapted to closely related drugs, for example, the cisplatin- and oxaliplatin-resistant UKF-NB-3 sublines and the vincristine- and vinblastine-adapted IMR-5 sublines, also displayed clearly distinctive patterns. In conclusion, intact whole-cell MALDI-ToF mass spectrometry has the potential to be further developed into an authentication method for mammalian cells of a common genetic origin.
- 21 May 2019
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (9) , 2339-2352
Improving the accuracy of flux balance analysis through the implementation of carbon availability constraints for intracellular reactions
Constraint‐based modeling methods, such as Flux Balance Analysis (FBA), have been extensively used to decipher complex, information rich ‐omics datasets to elicit system‐wide behavioral patterns of cellular metabolism. FBA has been successfully used to gain insight in a wide range of applications, such as range of substrate utilization, product yields and to design metabolic engineering strategies to improve bioprocess performance. A well‐known challenge associated with large genome‐scale metabolic networks is that they result in underdetermined problem formulations. Consequently, rather than unique solutions, FBA and related methods examine ranges of reaction flux values that are consistent with the studied physiological conditions. The wider the reported flux ranges, the higher the uncertainty in the determination of basic reaction properties, limiting interpretability of and confidence in the results. Herein, we propose a new, computationally efficient approach that refines flux range predictions by constraining reaction fluxes on the basis of the elemental balance of carbon. We compared carbon constraint FBA (ccFBA) against experimentally‐measured intracellular fluxes using the latest CHO GEM (iCHO1766) and were able to substantially improve the accuracy of predicted flux values compared with FBA. ccFBA can be used as a stand‐alone method but is also compatible with and complimentary to other constraint‐based approaches.
- 21 May 2019
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 116 (9) , 2339-2352
Improving the accuracy of flux balance analysis through the implementation of carbon availability constraints for intracellular reactions
Constraint‐based modeling methods, such as Flux Balance Analysis (FBA), have been extensively used to decipher complex, information rich ‐omics datasets to elicit system‐wide behavioral patterns of cellular metabolism. FBA has been successfully used to gain insight in a wide range of applications, such as range of substrate utilization, product yields and to design metabolic engineering strategies to improve bioprocess performance. A well‐known challenge associated with large genome‐scale metabolic networks is that they result in underdetermined problem formulations. Consequently, rather than unique solutions, FBA and related methods examine ranges of reaction flux values that are consistent with the studied physiological conditions. The wider the reported flux ranges, the higher the uncertainty in the determination of basic reaction properties, limiting interpretability of and confidence in the results. Herein, we propose a new, computationally efficient approach that refines flux range predictions by constraining reaction fluxes on the basis of the elemental balance of carbon. We compared carbon constraint FBA (ccFBA) against experimentally‐measured intracellular fluxes using the latest CHO GEM (iCHO1766) and were able to substantially improve the accuracy of predicted flux values compared with FBA. ccFBA can be used as a stand‐alone method but is also compatible with and complimentary to other constraint‐based approaches.
- 18 April 2018
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 72 (4) , 438-450
Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development
Monoclonality of mammalian cell lines used for production of biologics is a regulatory expectation and one of the attributes assessed as part of a larger process to ensure consistent quality of the biologic. Historically, monoclonality has been demonstrated through statistics generated from limiting dilution cloning or through verified flow cytometry methods. A variety of new technologies are now on the market with the potential to offer more efficient and robust approaches to generating and documenting a clonal cell line.
- 18 April 2018
- Published by Parenteral Drug Association, Inc. in PDA Journal of Pharmaceutical Science and Technology
- Vol. 72 (4) , 438-450
Implementation of Plate Imaging for Demonstration of Monoclonality in Biologics Manufacturing Development
Monoclonality of mammalian cell lines used for production of biologics is a regulatory expectation and one of the attributes assessed as part of a larger process to ensure consistent quality of the biologic. Historically, monoclonality has been demonstrated through statistics generated from limiting dilution cloning or through verified flow cytometry methods. A variety of new technologies are now on the market with the potential to offer more efficient and robust approaches to generating and documenting a clonal cell line.
- Open Access
- 1 June 2017
- Published by Elsevier in Journal of Biotechnology
- Vol. 251, 160-165
Extraction of indirectly captured information for use in a comparison of offline pH measurement technologies
- 1 June 2017
- Published by Elsevier in Journal of Biotechnology
- Vol. 251, 160-165
Open AccessExtraction of indirectly captured information for use in a comparison of offline pH measurement technologies
- Open Access
- 29 March 2017
- Published by Wiley in Biotechnology Progress
- Vol. 33 (2) , 337-346
Comparison of spectroscopy technologies for improved monitoring of cell culture processes in miniature bioreactors
Cell culture process development requires the screening of large numbers of cell lines and process conditions. The development of miniature bioreactor systems has increased the throughput of such studies; however, there are limitations with their use. One important constraint is the limited number of offline samples that can be taken compared to those taken for monitoring cultures in large‐scale bioreactors. The small volume of miniature bioreactor cultures (15 mL) is incompatible with the large sample volume (600 µL) required for bioanalysers routinely used. Spectroscopy technologies may be used to resolve this limitation. The purpose of this study was to compare the use of NIR, Raman, and 2D‐fluorescence to measure multiple analytes simultaneously in volumes suitable for daily monitoring of a miniature bioreactor system. A novel design‐of‐experiment approach is described that utilizes previously analyzed cell culture supernatant to assess metabolite concentrations under various conditions while providing optimal coverage of the desired design space. Multivariate data analysis techniques were used to develop predictive models. Model performance was compared to determine which technology is more suitable for this application. 2D‐fluorescence could more accurately measure ammonium concentration (RMSECV 0.031 g L−1) than Raman and NIR. Raman spectroscopy, however, was more robust at measuring lactate and glucose concentrations (RMSECV 1.11 and 0.92 g L−1, respectively) than the other two techniques. The findings suggest that Raman spectroscopy is more suited for this application than NIR and 2D‐fluorescence. The implementation of Raman spectroscopy increases at‐line measuring capabilities, enabling daily monitoring of key cell culture components within miniature bioreactor cultures. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:337–346, 2017
- 29 March 2017
- Published by Wiley in Biotechnology Progress
- Vol. 33 (2) , 337-346
Open AccessComparison of spectroscopy technologies for improved monitoring of cell culture processes in miniature bioreactors
Cell culture process development requires the screening of large numbers of cell lines and process conditions. The development of miniature bioreactor systems has increased the throughput of such studies; however, there are limitations with their use. One important constraint is the limited number of offline samples that can be taken compared to those taken for monitoring cultures in large‐scale bioreactors. The small volume of miniature bioreactor cultures (15 mL) is incompatible with the large sample volume (600 µL) required for bioanalysers routinely used. Spectroscopy technologies may be used to resolve this limitation. The purpose of this study was to compare the use of NIR, Raman, and 2D‐fluorescence to measure multiple analytes simultaneously in volumes suitable for daily monitoring of a miniature bioreactor system. A novel design‐of‐experiment approach is described that utilizes previously analyzed cell culture supernatant to assess metabolite concentrations under various conditions while providing optimal coverage of the desired design space. Multivariate data analysis techniques were used to develop predictive models. Model performance was compared to determine which technology is more suitable for this application. 2D‐fluorescence could more accurately measure ammonium concentration (RMSECV 0.031 g L−1) than Raman and NIR. Raman spectroscopy, however, was more robust at measuring lactate and glucose concentrations (RMSECV 1.11 and 0.92 g L−1, respectively) than the other two techniques. The findings suggest that Raman spectroscopy is more suited for this application than NIR and 2D‐fluorescence. The implementation of Raman spectroscopy increases at‐line measuring capabilities, enabling daily monitoring of key cell culture components within miniature bioreactor cultures. © 2017 American Institute of Chemical Engineers Biotechnol. Prog., 33:337–346, 2017